Xinjun Lu

Also affiliated with University of California, San Francisco, Sun Yat-sen Memorial Hospital

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 8 papers. Top paper: “Role of the Mammalian Target of Rapamycin Pathway in Liver Cancer: From Molecular Genetics to Targeted Therapies”.

Role of the Mammalian Target of Rapamycin Pathway in Liver Cancer: From Molecular Genetics to Targeted Therapies

Hepatology(2020)10.1002/hep.31310

N/A

0DataRank · unranked

123 citations

Panagiotis Paliogiannis, Diego F. Calvisi, Xin Chen, Xinjun Lu

Cabozantinib-based combination therapy for the treatment of hepatocellular carcinoma

Gut(2020)10.1136/gutjnl-2020-320716

N/A

0DataRank · unranked

107 citations

Xinhua Song, Pan Wang, Yi Zhou, Xinjun Lu, Jingxiao Wang +10 more

YAP Accelerates Notch-Driven Cholangiocarcinogenesis via mTORC1 in Mice

American Journal Of Pathology(2021)10.1016/j.ajpath.2021.05.017

N/A

0DataRank · unranked

59 citations

Baogang Peng, Ge Chen, Giovanni Mario Pes, Silvia Ribback, Cindy Ament +10 more

Combination of AFP vaccine and immune checkpoint inhibitors slows hepatocellular carcinoma progression in preclinical models

Journal of Clinical Investigation(2023)10.1172/jci163291

N/A

0DataRank · unranked

40 citations

Shanshan Deng, Jiejie Xu, Benjamin L. Green, Honghua Zhang, Guofei Cui +13 more

Preclinical and clinical studies of immunotherapy for the treatment of cholangiocarcinoma

JHEP Reports(2023)10.1016/j.jhepr.2023.100723

N/A

0DataRank · unranked

10 citations

Benjamin L. Green, Changqing Xie, Chao Liu, Xin Chen, Xinjun Lu

MAD2L1 supports MYC-driven liver carcinogenesis in mice and predicts poor prognosis in human hepatocarcinoma

Toxicological Sciences(2024)10.1093/toxsci/kfae126

N/A

0DataRank · unranked

3 citations

Ya Zhang, Jiahao Xue, Matthias Evert, Diego F. Calvisi, Xin Chen +2 more

Overexpression of TBX3 suppresses tumorigenesis in experimental and human cholangiocarcinoma

Cell Death and Disease(2024)10.1038/s41419-024-06839-8

N/A

0DataRank · unranked

2 citations

Xinjun Lu, Xue Wang, Binyong Liang, Hongwei Xu, Doris Yang +12 more

Inhibition of GSK3 and TSC2 Mediates the Oncogenic Activity of AKT in Hepatocellular Carcinoma

Cancer Research(2025)10.1158/0008-5472.can-25-1615

N/A

0DataRank · unranked

3 citations

Yi Zhou, Weiting Liao, Eleonora Cossu, Matthias Evert, Shu Zhang +19 more